How Long Does COVID Typically Last for Most People?

Most people with COVID-19 feel sick for roughly one to two weeks, though the range is wide. A study of outpatients with mild to moderate illness found that symptoms lasted an average of about 10 days, and only around 29% considered their illness fully resolved by the end of the fourth week. The variant you catch, your vaccination status, your age, and your immune system all shift that timeline in meaningful ways. And for a sizable minority, some symptoms linger well beyond the acute phase, raising the question of where an ordinary case ends and long COVID begins.

The Typical Timeline for Mild to Moderate Cases

The most common experience, covering the vast majority of infections, is a mild to moderate illness that plays out over roughly a week and a half. A study tracking 282 patients with confirmed mild to moderate infections found they had symptoms for an average of about 10 days, with a range stretching from just one day to over five weeks.¹ That average masks the reality that COVID tends to be a shapeshifting illness: early days often bring fatigue, body aches, and fever, while cough and congestion can arrive later and stick around longer.

A separate study following adult outpatients through their first four weeks found that COVID was more drawn out than many expected. Symptoms evolved rather than simply fading, and by week four, fewer than a third of participants said they felt completely recovered.² That does not mean most people are bedridden for a month. Many felt substantially better within the first two weeks but still had lingering symptoms like fatigue or occasional cough that took additional time to clear.

How the Variant Matters

The virus that circulates today is not the same one that spread in 2020, and the variant makes a real difference to how long you feel sick. The ZOE COVID Study, a large prospective study from the UK, directly compared matched groups infected during the Delta and Omicron waves. Among people who recovered within three weeks, those infected with Omicron had a median symptom duration of five days, compared to eight days for Delta.³ People infected during the Omicron wave were roughly two and a half times as likely to recover within a week compared to those infected during Delta dominance.

The picture was even more striking for people who had received three vaccine doses. In that group, Omicron infections lasted a median of just three days, versus seven days for Delta.³ That said, not every study found such dramatic differences between Omicron subvariants and Delta. A study comparing non-hospitalized adults across Delta and several Omicron sublineages (BA.1, BA.2, BA.4/5) found overall illness duration was similar at a median of about eight days across groups.⁴ The discrepancy probably reflects differences in how “recovery” was defined and measured, but the direction of the evidence is clear: more recent variants tend to produce shorter acute illness, especially in vaccinated people.

The symptom profile has also shifted over time. During the Omicron era, cough and sore throat became more common, while the hallmark early-pandemic symptom of losing your sense of smell dropped dramatically. During the pre-Delta period, about 17% of people testing positive reported loss of taste or smell; during Omicron BA.1, only about 5% did.⁵

When You Stop Being Contagious

Feeling sick and being infectious are not on the same clock. Most transmission happens very early, in the day or two before symptoms start and the two to three days after. By about five days into illness, your contagiousness has dropped substantially, which is why many public health guidelines settled on a five-day isolation window. But “substantially dropped” is not the same as “gone.”

A study of university students during an Omicron wave found that 47% of those screened twice weekly still tested positive on a rapid antigen test on day five, with the percentage roughly halving each additional day after that.⁶ So while five days is a practical cutoff for most people, it is one to two days too short for a substantial fraction, especially in settings where vulnerable people are nearby.

Vaccination has a clear effect here too. In one study, vaccinated individuals who developed breakthrough infections had a median of just two days of detectable virus by PCR, compared to about 16 and a half days for unvaccinated people experiencing their first infection.⁷ That is a dramatic reduction in the window during which you could pass the virus along.

What About Loss of Smell and Taste?

For people who do lose their sense of smell or taste, those symptoms tend to follow their own timeline. A systematic review found that anosmia and taste loss typically appeared about four to five days after other symptoms and began to resolve within about a week, with the most noticeable improvement in the first two weeks.⁸ For most people, these senses return to normal within a few weeks. A small minority, though, have experienced smell and taste distortion lasting months or longer, a symptom that overlaps with long COVID and ranks among its most distinctive features.⁹

Symptom Rebound

One frustrating pattern that many people experienced during the pandemic was feeling clearly better, only to have symptoms return a few days later. This symptom rebound happens even without antiviral treatment. Among untreated participants in a placebo-controlled trial, about 27% experienced some degree of symptom rebound after initial improvement, and about 10% had a rebound after symptoms had fully resolved.¹⁰ People with higher initial symptom scores and higher viral loads at baseline were more likely to experience it.

Paxlovid (nirmatrelvir-ritonavir) drew attention for causing rebound, but the comparison with untreated patients is instructive. One prospective study found symptom rebound in about 19% of Paxlovid-treated patients versus 7% of untreated controls.¹¹ So Paxlovid does appear to increase the chance of rebound, but rebound is not unique to it. Remdesivir, by contrast, was associated with almost no rebound in one study of 155 patients, where only a single immunocompromised patient experienced it.¹²

If you experience rebound, it does not mean you caught COVID again. It is part of the same infection, and rebound episodes are generally milder than the initial bout. They do, however, extend the overall duration of illness and may extend the window during which you can transmit the virus.

How Vaccination Shortens Things

Beyond the variant-specific numbers already described, vaccination consistently shortens both the illness itself and its practical consequences. A multicenter study of healthcare workers found that fully vaccinated employees missed about one and a half fewer days of work than those who were not fully vaccinated, with the fully vaccinated group absent for an average of about eight days versus nearly ten for the unvaccinated group.¹³ The effect was especially pronounced for people who had been recently boosted. The ZOE COVID Study data showed that a third dose of vaccine, combined with Omicron infection, compressed median illness to about three days, the shortest combination observed in any large study.³

Children Versus Adults

Children generally have shorter and milder acute illness than adults. A nationwide cohort study found that among children who tested positive for SARS-CoV-2, fewer than 1% reported symptoms lasting more than four weeks.¹⁴ When longer symptoms did occur, they typically resolved within one to five months. The risk of long COVID after reinfection also appeared lower in children under 16 than in adults, with no statistically significant increase after a second infection.¹⁵

For adults, the story is more variable. The same reinfection study found that about 4% of adults reported long COVID after a first infection, though the rate was lower after second infections (about 2.4%).¹⁵ Older adults and those with chronic conditions generally take longer to recover from the acute phase as well, consistent with the patterns seen in most respiratory infections.

Immunocompromised People Face a Different Timeline

For people with weakened immune systems, COVID can follow an entirely different course. Instead of the virus being cleared within a couple of weeks, immunocompromised patients may shed viable virus for months. Research has documented that severely immunocompromised individuals, whose ability to clear the virus is impaired, can remain infectious for extended periods.¹⁶ A multicenter cohort study found that persistent viral shedding beyond eight weeks in immunocompromised patients was associated with higher mortality and increased risk of invasive fungal infections.¹⁷

People without symptoms can also shed virus for surprisingly long periods. One study found that asymptomatic individuals shed virus for a median of 28 days, compared to about 11 and a half days for those who were infected before developing symptoms.¹⁸ It is important to note that viral shedding measured by PCR does not always mean someone is contagious, since the test can pick up fragments of non-viable virus. Still, the disconnect between feeling fine and still carrying detectable virus is real.

When Acute COVID Becomes Long COVID

There is no single agreed-upon date when acute COVID ends and long COVID begins, but most definitions center on symptoms persisting beyond about 12 weeks after infection. The condition involves not recovering for several weeks or months after symptom onset, regardless of whether the initial infection was confirmed by a test.¹⁹ By that definition, a substantial number of people are affected. An updated meta-analysis estimated that about 35% of people who had COVID reported at least one lingering symptom within the first year, with pooled prevalence not declining much even at one to two years of follow-up.²⁰

Those numbers sound alarming, and they are likely inflated by how broadly “at least one symptom” captures things. A two-year longitudinal study that tracked patients more carefully found that about a third developed long COVID by the 90-day cutoff, but symptoms peaked at around six months and then gradually improved. By 24 months, only about 8% had still not returned to their pre-COVID health.²¹ So while long COVID is real and common, for most people who develop it, symptoms do eventually resolve.

The data from a German cohort study echoed this trajectory. Of those who had symptoms between 4 and 12 weeks after infection, about half reported no symptoms after the 12-week mark. Men, younger people, those with milder initial infections, and those infected with Omicron were more likely to recover early.²²

What Drives Long COVID Biologically

The mechanisms behind long COVID are still being worked out, but research points to several overlapping processes rather than a single cause. Some people with long COVID have detectable viral proteins in their blood for up to a year after infection, suggesting the virus (or fragments of it) may persist in certain tissues. Immune dysfunction and chronic inflammation also appear to play a role, with studies showing upregulated viral RNA in the blood of people with long COVID and markers of an immune system that has not properly stood down.²³ The most common long-term symptoms, compared to people who never had COVID, are loss of smell, loss of taste, poor concentration, memory problems, and hair loss.⁹

Getting Back to Work and Normal Life

The practical question most people want answered is not how long the virus is detectable but when they can return to their normal routine. For the average employed person, COVID means more time away from work than the flu. One study tracking return-to-work rates across the pandemic found a median return of 10 days after COVID versus 6 days after flu-like symptoms. About 5.5% of employees who caught COVID were absent for over 12 weeks.²⁴

A U.S. database analysis painted a starker picture for people who filed disability claims. The mean short-term disability claim for COVID lasted 24 days, compared to 10 for influenza. The small number of long-term disability claims for COVID averaged 153 days.²⁵ These are not typical cases; they represent the tail end of severity. But they illustrate that for a minority of people, the functional impact of COVID extends far beyond the acute illness.

In a hospital-based study, 43% of employees had a delayed return to work beyond their mandatory isolation period, with a median time off of 14 days.²⁶ The gap between “allowed to return” and “able to return” is one that many people experienced firsthand: even after isolation ended, fatigue and lingering symptoms kept them out longer.

Does a Second Infection Last as Long as the First?

With reinfection now common, people often wonder whether each round of COVID is as bad as the last. The available data suggests that second infections tend to be shorter and less likely to lead to long COVID in adults. A community-based cohort study found that the odds of developing long COVID after a second infection were about 28% lower than after a first infection in adults over 16.¹⁵ That reduction likely reflects a combination of prior immunity priming the immune response and the fact that later infections tended to be caused by milder variants. It is worth noting, though, that the risk is not zero. Each infection is another roll of the dice, and some people who sailed through a first case develop long COVID after a second or third.